| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/1993 | US5179097 Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids |
| 01/12/1993 | US5179096 Therapeutic application of flouroquinolone derivatives |
| 01/12/1993 | US5179091 Chalcones |
| 01/12/1993 | US5179089 Isoquinoline compounds, compositions and use |
| 01/12/1993 | US5179088 Administering bactericides |
| 01/12/1993 | US5179087 Antibody inhibitors |
| 01/12/1993 | US5179086 Containing cholesterol for treatment of psoriasis |
| 01/12/1993 | US5179078 Method of suppressing tumor formation in vivo |
| 01/12/1993 | US5179001 In cystic fibrosis patients |
| 01/12/1993 | US5178880 Bactericides for urinary tract infections |
| 01/12/1993 | US5178879 Capsaicin gel |
| 01/12/1993 | US5178877 Cardiovascular disorders |
| 01/12/1993 | US5178876 Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 01/12/1993 | US5178875 Phosphatides with tert-butanol, clarification of water, mixing with solvent then removal |
| 01/12/1993 | US5178873 For inhibiting phospholipase; administering stearidonic acid |
| 01/12/1993 | US5178870 Varnish and chlorhexidine or salt; anticaries agents |
| 01/12/1993 | US5178854 Administering anion exchange resin containing inorganic quaternary ammonium salt monomer |
| 01/12/1993 | US5178852 Cosmetic and pharmaceutical compositions containing lipophilic derivatives of benzylidenecamphor and new lipophilic derivatives of benzylidenecamphor |
| 01/12/1993 | CA2073755A1 Compositions for slowing down hair loss and inducing and stimulating hair growth containing 2,4-diaminopyrimidine-3-oxide, and novel 2,4-diaminopyrimidine-3-oxide derivatives |
| 01/12/1993 | CA1312702C Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use |
| 01/12/1993 | CA1312616C Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 01/12/1993 | CA1312609C Preparation of a piperidinylclopentylheptenoic acid derivative |
| 01/12/1993 | CA1312608C Unsaturated phosphonic acids and derivatives |
| 01/12/1993 | CA1312607C Antibacterial agents and potentiators of carbapenem antibiotics |
| 01/12/1993 | CA1312605C 3-aryl-5-alkylthio-4h-1,2,4-triazoles |
| 01/12/1993 | CA1312599C 2',3'dideoxy-2',2'difluoronucleosides |
| 01/12/1993 | CA1312598C 4-demethoxy anthracycline derivatives |
| 01/12/1993 | CA1312549C Instant oral-release capsule containing nifedipine |
| 01/11/1993 | WO1993000881A1 Treatment of hair loss and dermatological problems |
| 01/11/1993 | CA2073499A1 Inhibitors of hiv protease useful for the treatment of aids |
| 01/11/1993 | CA2072394A1 Phosphorus-containing hmg-coa reductase inhibitors |
| 01/11/1993 | CA2071137A1 Composition and method for revitalizing scar tissue |
| 01/10/1993 | WO1993000907A1 Use of a 2-deoxystreptamine-type antibiotic |
| 01/10/1993 | CA2091264A1 Use of a 2-deoxystreptamine-type antibiotic |
| 01/10/1993 | CA2073396A1 Pharmaceutical agent for treatment of withdrawal symptons |
| 01/10/1993 | CA2073377A1 2-(2-substituted pyrrolidinylthio) carbapenem derivatives |
| 01/10/1993 | CA2073281A1 Isatineoxime derivatives, their preparation and use |
| 01/10/1993 | CA2046519A1 Non-smoking aid |
| 01/09/1993 | CA2073326A1 Method of inhibiting sucrase activity |
| 01/07/1993 | WO1993000348A1 Dimethylamino-hydroxy-alkan diphosphonic acids and pharmaceutical compositions containing them |
| 01/07/1993 | WO1993000344A1 Carbapenem derivative |
| 01/07/1993 | WO1993000343A1 Thiazolidinedione hypoglycemic agents |
| 01/07/1993 | WO1993000342A1 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract |
| 01/07/1993 | WO1993000341A1 4-(1-h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity |
| 01/07/1993 | WO1993000339A1 A novel salicylic acid-maltol conjugates |
| 01/07/1993 | WO1993000337A1 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
| 01/07/1993 | WO1993000335A1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
| 01/07/1993 | WO1993000333A1 Tryptamine analogues, their synthesis and their use as 5-ht1-like or 5-ht2 receptor agonists |
| 01/07/1993 | WO1993000332A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 01/07/1993 | WO1993000331A1 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 01/07/1993 | WO1993000330A2 Azanorbornane derivatives |
| 01/07/1993 | WO1993000329A1 Chemical process |
| 01/07/1993 | WO1993000313A2 Sigma receptor ligands and the use thereof |
| 01/07/1993 | WO1993000114A1 Topical composition enhancing healing of herpes lesions |
| 01/07/1993 | WO1993000101A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 01/07/1993 | WO1993000099A2 Use of pyrimidine and purine nucleosides for the prophylaxis and/or treatment of infections caused by adenoviruses |
| 01/07/1993 | WO1993000098A1 Method for treating helicobacter pylori gastritis |
| 01/07/1993 | WO1993000097A1 Pharmaceutical preparations containing torasemid |
| 01/07/1993 | WO1993000096A1 Topical application of steroid hormones and vaginocervical stimulation to induce maternal behaviour of animals |
| 01/07/1993 | WO1993000095A2 Bicyclic fibrinogen antagonists |
| 01/07/1993 | WO1993000094A2 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| 01/07/1993 | WO1993000093A1 Extended-release form of diltiazem |
| 01/07/1993 | WO1993000092A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 01/07/1993 | WO1993000091A1 Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol |
| 01/07/1993 | WO1993000090A1 Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol |
| 01/07/1993 | WO1993000088A1 Use of phenylpyrazoline derivatives for the treatment of elevated intraocular pressure |
| 01/07/1993 | WO1993000087A1 Porphycene compounds for photodynamic therapy |
| 01/07/1993 | WO1993000086A1 Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists |
| 01/07/1993 | WO1993000085A1 Stabilized retinoid-containing skin care compositions |
| 01/07/1993 | WO1993000084A1 Methods and compositions for treating malaria and other diseases |
| 01/07/1993 | WO1993000083A1 Pharmaceutical composition containing gamma-hydroxybutyric acid or its lactone in the treatment of drug dependence and nutritional disorders |
| 01/07/1993 | WO1993000081A1 Optically pure s(-) nadolol for treatment of cardiovascular disorders |
| 01/07/1993 | WO1993000080A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| 01/07/1993 | WO1993000079A1 Method of preventing and treating chemotherapy-induced alopecia |
| 01/07/1993 | WO1993000075A1 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 01/07/1993 | WO1993000074A1 Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| 01/07/1993 | WO1993000072A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 01/07/1993 | WO1993000071A1 Dosage form for a delayed drug delivery |
| 01/07/1993 | WO1993000070A1 Controlled release systems and low dose androgens |
| 01/07/1993 | WO1993000067A1 Cosmetic compositions containing oligosaccharides |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1992021654A3 Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives |
| 01/07/1993 | WO1992021333A3 Treatment of drug withdrawal symptoms and drug craving with type b monoamine oxidase inhibitors |
| 01/07/1993 | WO1992021313A3 Novel immunosuppressive compounds |
| 01/07/1993 | WO1992019234A3 Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins |
| 01/07/1993 | WO1992019233A3 Sustained release composition and methods of use thereof |
| 01/07/1993 | WO1992019182A3 Method of attenuation of neointimal proliferation |
| 01/07/1993 | WO1992017173A3 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
| 01/07/1993 | WO1992015561A3 Process for preparing trans-piperidine-2,5-dicarboxylates |
| 01/07/1993 | WO1992014438A3 Prostacycline and carbacycline derivatives as agents for treating feverish complaints |
| 01/07/1993 | EP0521827A1 Pharmacological active hydrazin derivatives and process for their preparation |
| 01/07/1993 | EP0521799A1 Ophthalmic compositions |
| 01/07/1993 | EP0521787A1 Vanadium complexes, their preparation and pharmaceutical compositions containing them |
| 01/07/1993 | EP0521781A1 Pyrethinoide esters of 2,3-dihydro 4-methyl 2-oxo 3-(2-propynyl) thiazole-2-methanol, process for their preparation and their use as pesticides |
| 01/07/1993 | EP0521768A1 Thiazolopyrimidine derivatives as angiotensin II-receptor antagonists: processes for their preparation and pharmaceutical compositions containing them |
| 01/07/1993 | EP0521766A1 Method for the synthesis of enantiomers of 3-aminochroman derivatives |
| 01/07/1993 | EP0521692A2 Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them |
| 01/07/1993 | EP0521680A1 3-Oxygermylpropionic acid compressed compositon and its use against cytopathogenic substances |
| 01/07/1993 | EP0521622A1 Pyrazolopyrimidine and pyrimidinyl bisphosphonic esters as anti-inflammatories |